BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

277 related articles for article (PubMed ID: 19195508)

  • 1. Outcome differences with the use of drug-eluting stents for the treatment of in-stent restenosis of bare-metal stents versus drug-eluting stents.
    Steinberg DH; Gaglia MA; Pinto Slottow TL; Roy P; Bonello L; De Labriolle A; Lemesle G; Torguson R; Kineshige K; Xue Z; Suddath WO; Kent KM; Satler LF; Pichard AD; Lindsay J; Waksman R
    Am J Cardiol; 2009 Feb; 103(4):491-5. PubMed ID: 19195508
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Natural history of coronary stents: 14 year follow-up of drug eluting stents versus bare metal stents.
    Walse RS; Mohanan Nair KK; Valaparambil A; Sasidharan B; Sivadasapillai H; Thulaseedharan JV
    Indian Heart J; 2023; 75(6):457-461. PubMed ID: 37926420
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Drug-eluting stents versus bare metal stents in ST elevation myocardial infarction at a follow-up of three years or longer: A meta-analysis of randomized trials.
    Sethi A; Bahekar A; Bhuriya R; Bajaj A; Kovacs D; Ahmed A; Khosla S
    Exp Clin Cardiol; 2012; 17(4):169-74. PubMed ID: 23592929
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical Coronary In-Stent Restenosis Follow-Up after Treatment and Analyses of Clinical Outcomes.
    Marino BC; Nascimento GA; Rabelo W; Marino MA; Marino RL; Ribeiro AL
    Arq Bras Cardiol; 2015 May; 104(5):375-86. PubMed ID: 25651344
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of pioglitazone on in-stent restenosis after coronary drug-eluting stent implantation: a meta-analysis of randomized controlled trials.
    Zhang MD; Zhang YH; Zhu EJ; Qiao SB; Lv SZ; Zhao QM
    PLoS One; 2014; 9(10):e109614. PubMed ID: 25279761
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A prediction model based on platelet parameters, lipid levels, and angiographic characteristics to predict in-stent restenosis in coronary artery disease patients implanted with drug-eluting stents.
    Gai MT; Zhu B; Chen XC; Liu F; Xie X; Gao XM; Ma X; Fu ZY; Ma YT; Chen BD
    Lipids Health Dis; 2021 Sep; 20(1):118. PubMed ID: 34587955
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A tale of two in stent restenosis in same patient: Surprising findings from optical coherence tomography.
    Pradhan A; Roy S; Chaudhary G; Vishwakarma P; Chandra S; Hasibuzzaman MA
    Clin Case Rep; 2023 Nov; 11(11):e8222. PubMed ID: 38028098
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Association of Endothelial Nitric Oxide Synthase and Angiotensin-Converting Enzyme Genes Polymorphism With In-Sent Restenosis of Bare Metal Stents vs Drug-Eluting Stents in Egyptians.
    Abdelaziz TA; Mohamed RH; Saadawy SF
    Angiology; 2023 Dec; ():33197231219837. PubMed ID: 38039959
    [TBL] [Abstract][Full Text] [Related]  

  • 9. STENTING STRATEGY AND FOLLOW-UP RESULTS OF MULTI-CENTER REGISTRY IN FUKUSHIMA CITY FOR LEFT MAIN CORONARY ARTERY DISEASE: BARE METAL STENT VERSUS DRUG-ELUTING STENT.
    Nakazato K; Mizukami H; Ohtake H; Sakamoto N; Yamaki T; Yamaguchi O; Kunii H; Ohwada T; Takeishi Y
    Fukushima J Med Sci; 2015; 61(1):79-85. PubMed ID: 26135665
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Serum glycated albumin is associated with in-stent restenosis in patients with acute coronary syndrome after percutaneous coronary intervention with drug-eluting stents: An observational study.
    Lin XL; Li QY; Zhao DH; Liu JH; Fan Q
    Front Cardiovasc Med; 2022; 9():943185. PubMed ID: 36237913
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Outcomes of Drug-Eluting Balloons for In-Stent Restenosis: Large Cohort Analysis and Single-Center Clinical Experience.
    Kheifets M; Rahat O; Bental T; Levi A; Vaknin-Assa H; Greenberg G; Codner P; Witberg G; Kornowski R; Perl L
    Can J Cardiol; 2024 Jan; ():. PubMed ID: 38211886
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Drug eluting stents: To evolve or dissolve?
    Bharadwaj P; Chadha DS
    Med J Armed Forces India; 2016 Oct; 72(4):367-372. PubMed ID: 27843185
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evolution of Coronary Stent Platforms: A Brief Overview of Currently Used Drug-Eluting Stents.
    Brami P; Fischer Q; Pham V; Seret G; Varenne O; Picard F
    J Clin Med; 2023 Oct; 12(21):. PubMed ID: 37959177
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ten-year outcomes after percutaneous coronary intervention of in-stent restenosis in saphenous vein grafts.
    Kuna C; Wiedenmayer N; Bradaric C; Presch A; Voll F; Kufner S; Ibrahim T; Schunkert H; Laugwitz KL; Cassese S; Kastrati A; Wiebe J
    Catheter Cardiovasc Interv; 2023 Oct; 102(4):646-654. PubMed ID: 37605515
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Intracoronary brachytherapy for in-stent restenosis of drug-eluting stents.
    Ohri N; Sharma S; Kini A; Baber U; Aquino M; Roy S; Sheu RD; Buckstein M; Bakst R
    Adv Radiat Oncol; 2016; 1(1):4-9. PubMed ID: 28799576
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prognostic impact of in-stent restenosis in normal weight, overweight, and obese patients undergoing percutaneous coronary intervention.
    Jones D; Spirito A; Sartori S; Vogel B; Edens M; Kamaleldin K; Pileggi B; Baber U; Dangas G; Sharma SK; Kini A; Mehran R
    Catheter Cardiovasc Interv; 2024 Feb; 103(2):260-267. PubMed ID: 38173300
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Late stent thrombosis, endothelialisation and drug-eluting stents.
    Ertaş G; van Beusekom HM; van der Giessen WJ
    Neth Heart J; 2009 Apr; 17(4):177-80. PubMed ID: 19421365
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Recurrent Intra-Stent Coronary Restenosis in a Carrier of Non-Disease-Specific Antinuclear Antibodies.
    Tomberli B; Fumagalli S; Minopoli TC; Menale S; Scheggi V; Marchionni N
    Eur J Case Rep Intern Med; 2024; 11(5):004412. PubMed ID: 38715879
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A Novel Score for an Old Enemy: Atherogenic Plasma Index Predicts In-Stent Restenosis among Stable Angina Pectoris Patients.
    Ser OS; Sigirci S; Keskin K; Cetinkal G; Kocas BB; Kilci H; Dalgic Y; Kalender E; Kilickesmez K
    Sisli Etfal Hastan Tip Bul; 2024; 58(1):75-81. PubMed ID: 38808058
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Association between Oxidative Burden and Restenosis: A Case-Control Study.
    Ganjali S; Mansouri A; Abbasifard M; Moallem SA; Tayarani-Najaran Z; Sahebkar A
    Oxid Med Cell Longev; 2022; 2022():3577761. PubMed ID: 35799893
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.